Top

Published in:

31-03-2022 | Osteoporosis | Original Article

A 2-year follow-up of a novel Fracture Liaison Service: can we reduce the mortality in elderly hip fracture patients? A prospective cohort study

Authors: D. González-Quevedo, V. Pérez-del-Río, D. Moriel-Garceso, N. Fernández-Arroyabe, G. García-Meléndez, M. Montañez-Ruiz, M. Bravo-Bardají, D. García-de-Quevedo, I. Tamimi

Published in: Osteoporosis International | Issue 8/2022

Abstract

Summary

Osteoporosis is an underdiagnosed disease that results in bone fragility and risk of fractures. Fracture Liaison Service (FLS) is a secondary prevention model which identifies patients at risk for fragility fractures. The introduction of a FLS protocol showed an increase of anti-osteoporotic drug prescription and significant reduction of all-cause mortality.

Introduction

Hip fractures are the most severe osteoporotic fracture due to their associated disability and elevated risk of mortality. FLS programs have enhanced the management of osteoporosis-related fractures. Our objective is to analyze the effect of the FLS model over survival and 2-year mortality rate following a hip fracture.

Methods

We conducted a prospective cohort study on patients over 60 years of age who suffered a hip fracture during 3 consecutive years, before and after the implementation of the FLS in our center (i.e., between January 2016 and December 2018). Patients’ information was withdrawn from our local computerized database. Patients were followed for 2 years after the hip fracture. Mortality and re-fracture rates were compared between the two groups using a multivariate Cox proportional hazard model.

Results

A total of 1101 patients were included in this study (i.e., 357 before FLS implementation and 744 after FLS implementation). Anti-osteoporotic drugs were more frequently prescribed after FLS implementation (583 (78.4%) vs 44 (12.3%); p < 0.01). There was an increase of adherence to treatment after FLS implementation (227 (38.9%) vs 12 (3.3%); p = 0.03). A total of 222 (29.8%) patients after FLS implementation and 114 (31.9%) individuals before FLS implementation (p = 0.44) died during the follow-up period. A second fracture occurred in 49 (6.6%) patients after FLS implementation and in 26 (7.3%) individuals before FLS implementation (p = 0.65). Patients who were treated with anti-osteoporotic drugs after the implementation of the FLS protocol had a lower all-cause 1-year and 2-year mortality compared with patients managed before the implementation of the FLS protocol (adjusted hazard ratio (HR) 0.75, 95% confidence interval (CI) 0.59–0.96; HR 0.87, 95% CI 0.69–1.09, respectively).

Conclusions

The implementation of a FLS protocol was associated with an increase of anti-osteoporotic treatment, higher adherence, and greater survival in elderly hip fracture patients. There was a significant reduction of all-cause mortality in the FLS patients treated with anti-osteoporotic. However, the application of the FLS did not affect the risk of suffering a second fragility fracture.

Johnston CB, Dagar M (2020) Osteoporosis in older adults. Med Clin North Am 104:873–884. https://doi.org/10.1016/j.mcna.2020.06.004CrossRefPubMed

for the International Osteoporosis Foundation, Borgström F, Karlsson L et al (2020) Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos 15:59. https://doi.org/10.1007/s11657-020-0706-yCrossRef

Veronese N, Maggi S (2018) Epidemiology and social costs of hip fracture. Injury 49:1458–1460. https://doi.org/10.1016/j.injury.2018.04.015CrossRefPubMed

Kim SC, Kim M-S, Sanfélix-Gimeno G et al (2015) Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study. Am J Med 128:519-526.e1. https://doi.org/10.1016/j.amjmed.2015.01.014CrossRefPubMedPubMedCentral

IOF Fracture Working Group, Åkesson K, Marsh D et al (2013) Capture the fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24:2135–2152. https://doi.org/10.1007/s00198-013-2348-zCrossRefPubMedCentral

Wu C-H, Tu S-T, Chang Y-F et al (2018) Fracture liaison services improve outcomes of patients with osteoporosis-related fractures: a systematic literature review and meta-analysis. Bone 111:92–100. https://doi.org/10.1016/j.bone.2018.03.018CrossRefPubMed

Shipman KE, Doyle A, Arden H et al (2017) Development of fracture liaison services: what have we learned? Injury 48:S4–S9. https://doi.org/10.1016/j.injury.2017.08.030CrossRefPubMed

González-Quevedo D, Bautista-Enrique D, Pérez-del-Río V et al (2020) Fracture liaison service and mortality in elderly hip fracture patients: a prospective cohort study. Osteoporos Int 31:77–84. https://doi.org/10.1007/s00198-019-05153-wCrossRefPubMed

on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF), Kanis JA, Cooper C et al (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30:3–44. https://doi.org/10.1007/s00198-018-4704-5CrossRef

10.

Barahona M, Barrientos C, Cavada G et al (2020) Survival analysis after hip fracture: higher mortality than the general population and delayed surgery increases the risk at any time. Hip Int 30:54–58. https://doi.org/10.1177/1120700020938029CrossRefPubMed

11.

Katsoulis M, Benetou V, Karapetyan T et al (2017) Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project. J Intern Med 281:300–310. https://doi.org/10.1111/joim.12586CrossRefPubMed

12.

the Ontario Osteoporosis Strategy Fracture Screening and Prevention Program Evaluation Team, Sujic R, Luo J et al (2020) Multiple simultaneous fractures are associated with higher all-cause mortality: results from a province-wide fracture liaison service. Osteoporos Int 31:291–296. https://doi.org/10.1007/s00198-019-05207-zCrossRef

13.

González Quevedo D, Mariño IT, Sánchez Siles JM et al (2017) Patient survival and surgical re-intervention predictors for intracapsular hip fractures. Injury 48:1831–1836. https://doi.org/10.1016/j.injury.2017.06.014CrossRefPubMed

14.

Li N, Hiligsmann M, Boonen A et al (2021) The impact of fracture liaison services on subsequent fractures and mortality: a systematic literature review and meta-analysis. Osteoporos Int 32:1517–1530. https://doi.org/10.1007/s00198-021-05911-9CrossRefPubMedPubMedCentral

15.

Kristensen PK, Ehrenstein V, Shetty N, Pedersen AB (2019) Use of anti-osteoporosis medication dispensing by patients with hip fracture: could we do better? Osteoporos Int 30:1817–1825. https://doi.org/10.1007/s00198-019-05066-8CrossRefPubMed

16.

Chau YT, Nashi N, Law LS-C et al (2020) Undertreatment of osteoporosis following hip fracture: a retrospective, observational study in Singapore. Arch Osteoporos 15:141. https://doi.org/10.1007/s11657-020-00816-2CrossRefPubMed

17.

Kuiper BW, Graybill S, Tate JM et al (2018) After the fall: improving osteoporosis treatment following hip fracture. Osteoporos Int 29:1295–1301. https://doi.org/10.1007/s00198-018-4416-xCrossRefPubMed

18.

On behalf of the European Society for Clinical and Economic Aspect of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), Cornelissen D, de Kunder S et al (2020) Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review. Osteoporos Int 31:1645–1669. https://doi.org/10.1007/s00198-020-05378-0CrossRef

19.

Delbar A, Pflimlin A, Delabrière I et al (2021) Persistence with osteoporosis treatment in patients from the Lille University Hospital Fracture Liaison Service. Bone 144:115838. https://doi.org/10.1016/j.bone.2020.115838CrossRefPubMed

20.

Yeam CT, Chia S, Tan HCC et al (2018) A systematic review of factors affecting medication adherence among patients with osteoporosis. Osteoporos Int 29:2623–2637. https://doi.org/10.1007/s00198-018-4759-3CrossRefPubMed

21.

Brozek W, Reichardt B, Zwerina J et al (2016) Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study. Osteoporos Int 27:387–396. https://doi.org/10.1007/s00198-015-3415-4CrossRefPubMed

22.

Sattui SE, Saag KG (2014) Fracture mortality: associations with epidemiology and osteoporosis treatment. Nat Rev Endocrinol 10:592–602. https://doi.org/10.1038/nrendo.2014.125CrossRefPubMed

23.

Charoenngam N, Shirvani A, Holick MF (2019) Vitamin D for skeletal and non-skeletal health: what we should know. J Clin Orthop Trauma 10:1082–1093. https://doi.org/10.1016/j.jcot.2019.07.004CrossRefPubMedPubMedCentral

24.

Chiodini I, Bolland MJ (2018) Calcium supplementation in osteoporosis: useful or harmful? Eur J Endocrinol 178:D13–D25. https://doi.org/10.1530/EJE-18-0113CrossRefPubMed

25.

Yusuf AA, Cummings SR, Watts NB et al (2018) Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women. Arch Osteoporos 13:33. https://doi.org/10.1007/s11657-018-0439-3CrossRefPubMedPubMedCentral

26.

Sanli I, van Helden SH, ten Broeke RHM et al (2019) The role of the Fracture Liaison Service (FLS) in subsequent fracture prevention in the extreme elderly. Aging Clin Exp Res 31:1105–1111. https://doi.org/10.1007/s40520-018-1054-2CrossRefPubMed

27.

de Bruin IJA, Wyers CE, van den Bergh JPW, Geusens PPMM (2017) Fracture liaison services: do they reduce fracture rates? Ther Adv Musculoskelet Dis 9:157–164. https://doi.org/10.1177/1759720X17706464CrossRefPubMedPubMedCentral

28.

Vandenbroucke A-M, Luyten F, Flamaing J, Gielen E (2017) Pharmacological treatment of osteoporosis in the oldest old. CIA 12:1065–1077. https://doi.org/10.2147/CIA.S131023CrossRef

29.

Black DM, Geiger EJ, Eastell R et al (2020) Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates. N Engl J Med 383:743–753. https://doi.org/10.1056/NEJMoa1916525CrossRefPubMed

30.

Kong SH, Hwang BK, Yoon B-H (2021) The impact of COVID-19 on the optimal management of osteoporosis. J Bone Metab 28:115–122. https://doi.org/10.11005/jbm.2021.28.2.115CrossRefPubMedPubMedCentral

Title: A 2-year follow-up of a novel Fracture Liaison Service: can we reduce the mortality in elderly hip fracture patients? A prospective cohort study
Authors: D. González-Quevedo
V. Pérez-del-Río
D. Moriel-Garceso
N. Fernández-Arroyabe
G. García-Meléndez
M. Montañez-Ruiz
M. Bravo-Bardají
D. García-de-Quevedo
I. Tamimi
Publication date: 31-03-2022
Publisher: Springer London
Keywords: Osteoporosis
Osteoporosis
Published in: Osteoporosis International / Issue 8/2022
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-022-06298-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A 2-year follow-up of a novel Fracture Liaison Service: can we reduce the mortality in elderly hip fracture patients? A prospective cohort study

Abstract

Summary

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2022

Fragility fracture patients with a history of prior fractures more likely to present with multiple risk factors: findings from a province-wide fracture liaison service

Associations between bone mineral density and subclinical peripheral arterial disease in elderly men with type 2 diabetes mellitus

Effect of degeneration on bone mineral density, trabecular bone score and CT Hounsfield unit measurements in a spine surgery patient population

Correction to: Risk of osteoporosis and fracture after hysterectomies without oophorectomies: a systematic review and pooled analysis

Risk of osteoporosis and fracture after hysterectomies without oophorectomies: a systematic review and pooled analysis

Associations of components of sarcopenia with risk of fracture in the Osteoporotic Fractures in Men (MrOS) study